Valuation Novavax, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-28 EDT			5-day change	1st Jan Change
9.260 ^USD	+2.32%		+9.98%	+37.80%

08-28	Novavax, Inc., Sanofi S.A., And Takeda Pharmaceutical Company Limited Receive Approvals For XFG-Adapted Nuvaxovid Formulation In The U.S., European Union And Japan For 2026-2027 Vaccination Season	CI
08-28	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update	DJ

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	10,817	883.9	570.2	1,288	1,092	1,493	-	-
Change	-	-91.83%	-35.49%	125.87%	-15.21%	36.7%	-	-
Enterprise Value (EV) ¹	9,756	-228.1	169.7	534.5	1,096	1,712	1,796	1,493
Change	-	-102.34%	174.39%	214.93%	104.99%	56.24%	4.92%	-16.88%
P/E	-6.1x	-1.22x	-0.89x	-6.54x	2.6x	-14.5x	-40.3x	37.7x
PBR	-30.9x	-1.38x	-0.93x	-2.07x	-8.55x	-2.58x	-2.47x	-
PEG	-	0x	0x	0.1x	-0x	0x	0.6x	-0x
Capitalization / Revenue	9.44x	0.45x	0.58x	1.89x	0.97x	4x	5.61x	4.83x
EV / Revenue	8.51x	-0.12x	0.17x	0.78x	0.98x	4.59x	6.75x	4.83x
EV / EBITDA	-	0.37x	-0.32x	-2.67x	2.28x	-14.2x	-36.2x	-176x
EV / EBIT	-5.78x	0.35x	-0.3x	-2.15x	2.42x	-17.4x	-57x	26.1x
EV / FCF	36.8x	0.45x	-0.22x	-5.33x	-4.38x	-7.54x	-38.2x	12.5x
FCF Yield	2.72%	221%	-452%	-18.8%	-22.8%	-13.3%	-2.62%	8%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-23.44	-8.42	-5.41	-1.23	2.58	-0.6251	-0.2243	0.2403
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,146	1,982	983.7	682.2	1,123	372.9	266.2	308.7
EBITDA ¹	-	-615.7	-525.3	-200.4	480.4	-120.9	-49.65	-8.459
EBIT ¹	-1,687	-644.7	-566.5	-248.9	452.8	-98.6	-31.49	57.14
Net income ¹	-1,744	-657.9	-545.1	-187.5	440.3	-107.5	-37.93	40.68
Net Debt ¹	-1,061	-1,112	-400.5	-753.4	3.579	219	303.2	-
Reference price ²	143.070	10.280	4.800	8.040	6.720	9.050	9.050	9.050
Nbr of stocks (in thousands)	75,608	85,979	118,790	160,185	162,499	164,946	-	-
Announcement Date	2/28/22	2/28/23	2/28/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVAVAX, INC.	-14.48x	4.59x	-14.16x	-.--%	1.49B
LONZA GROUP AG	34.55x	6.16x	18.31x	0.93%	51.14B
REVOLUTION MEDICINES, INC.	-22.47x	290.65x	-23.9x	-.--%	47.4B
IQVIA HOLDINGS INC.	33.79x	3.27x	14.13x	-.--%	43.19B
BEONE MEDICINES AG	48.79x	5.67x	30.99x	-.--%	42.35B
CELLTRION, INC.	29.05x	8.78x	22.18x	0.4%	33.23B
MEDPACE HOLDINGS, INC.	34.78x	5.7x	25.92x	-.--%	17.07B
EUROFINS SCIENTIFIC SE	24.34x	2.11x	9.14x	1.11%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	79.29x	4.16x	16.13x	-.--%	14.15B
Average	27.52x	36.79x	10.97x	0.27%	29.42B
Weighted average by Cap.	27.37x	56.50x	12.27x	0.29%